National and Kapodistrian University of Athens
Εφαρμογή της τεχνολογίας των λιποσωμάτων και δενδριμερών στο σχεδιασμό και τη μελέτη νέων χιμαιρικών νανοσυστημάτων μεταφοράς του αντικαρκινικού φαρμάκου δοξορουβικίνη
Abstract
dc:descriptionA plethora of drug molecules with significant biological activity, both in vitro and in vivo, have been found to be inactive during clinical trials. Nanotechnology seems to be the multiscientific field that will permit the clinical application of many of the above molecules. The formulation of a drug molecule with nanocarriers may alter the ADME (Administration, bioDistribution, Metabolism, Exertion) profile of the drug to a large extent. A new approach for nanocarrier design is the development of chimeric drug delivery systems that result from the combination of nanoparticles. The main representative category of chimeric drug delivery systems is liposomal locked-in dendrimers (LLDs) that result from the combination of liposomes and dendrimers. LLDs have been successfully developed in the past but there is a gap in the literature concerning the interactions of the parts of the final nanocarrier; information that is necessary for the rational design of such nanosystems. In the present study two new polyester-polyether dendrimers of generation one and two were synthesized. These dendrimers, as well as generation 3,5 commercial polyamidoamine (PAMAM) dendrimer, were incorporated into lipid bilayers or liposomes consisting of dipalmitoyl phosphatidylcholine and phosphatidylglcerol (DPPC-DPPG) and the interactions between dendrimers and lipids were studied with methods of thermal analysis, Raman spectroscopy and fluorescence spectroscopy. The derived information served as a basis for the incorporation of dendrimers into liposomes of various compositions and the final products (LLDs) were subjected to lyophilization. After reconstitution, the anticancer drug doxorubicin was loaded to both pure liposomes and LLDs and the interaction of the components of the final nanosystem, the in vitro release of doxorubicin and the in vitro pharmacological activity against human breast cancer cell lines were evaluated. The results that concern the interaction of the components of the nanocarrier were evaluated as very important and were correlated to the doxorubicin release rate.LLDs seem to be a very promising category of chimeric drug delivery systems. The rational choice of dendrimers and lipidic composition of liposomes may lead to original drug delivery sytems of the LLD category that may present controlled release rate and enhanced therapeutic index. The understanding of the dynamics and kinetics of the components of the LLD nanocarriers with thermal analysis and spectroscopic methods may lead to the development of novel drugs against cancer and other diseases.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Gardikis, Konstantinos
- Γαρδίκης, Κωνσταντίνος
Subjects
dc:subject × 22- Νανοτεχνολογία
- Λιποσώματα
- Δενδριμερές
- Χιμαιρικά νανοσυστήματα
- Δοξορουβικίνη
- Καρκίνος
- Λιποσωμιακά εγκλεισμένα δενδριμερή
- Nanotechnology
- Liposomes
- Dendrimers
- Chimeric nanaosystems
- Doxorubicin
- Cancer
- Liposomal locked in dendrimers
- Φυσικές Επιστήμες
- Χημεία
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Natural Sciences
- Chemical Sciences
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36495